Ahmet Dirican, Professor of Medical Oncology at Medicana International İzmir Hospital, shared a post on X:
“It is not every day that you see 10,000 oncologists rise to their feet and applaud.
That is exactly what happened at ASCO2026
For years, we have been looking at KRAS in pancreatic cancer. We knew how profoundly it drives this disease. But we could not touch it. Scientists called it “undruggable.”
Today, for the first time, we are beginning to do exactly that. This is not a declaration of victory. It is not the end of the journey. But it may be the beginning of a new chapter in the story of pancreatic cancer. Because for the first time in a very long time, the direction may be changing.”
